sa¹ú¼Ê´«Ã½

sa¹ú¼Ê´«Ã½

  • October 22, 2025

    Fed. Circ. Faults PTAB Ax In Centripetal Case But Not Recusal

    The Federal Circuit on Wednesday vacated the Patent Trial and Appeal Board's invalidation of Centripetal Networks LLC cybersecurity patent claims challenged by Cisco Systems Inc. in a high-stakes dispute, but rejected Centripetal's argument that the case was tainted by a PTAB judge's ownership of Cisco stock.

  • October 22, 2025

    Bristol-Myers $450M Payment Dispute Heads To Arbitration

    A judge sitting for Delaware's Court of Chancery has sent to arbitration allegations from shareholders of a small biotechnology company acquired by Bristol-Myers Squibb that the pharmaceutical giant used trickery to avoid paying up to $450 million in milestone payments.

  • October 22, 2025

    'Would-Be Bank Robbers': Reddit Says Perplexity Steals Data

    Perplexity AI Inc. and three data-scraping companies act like "would-be bank robbers" to bypass Reddit's data security measures and collect users' "continuous stream of real-time and creative copyrighted works" to feed the company's generative text products, Reddit alleges in a lawsuit filed Wednesday in New York federal court.

  • October 22, 2025

    Gilstrap, Albright Flouting Venue Law, Fed. Circ. Told

    The Federal Circuit is being asked to step in and decide if two well-known Texas federal judges, U.S. District Judges Rodney Gilstrap and Alan Albright, have been flouting patent venue law by refusing to transfer out infringement cases if any step of the patented method was performed in their section of the Lone Star State.

  • October 22, 2025

    Strava Drops Patent Suit Against Garmin Weeks After Filing

    Fitness app company Strava has agreed to drop a lawsuit filed last month accusing wearable device maker Garmin of infringing a trio of GPS patents for defining segments of road and mapping routes.

  • October 22, 2025

    USPTO Cuts TM Backlog Below 350K, Surpassing FY25 Goal

    The U.S. Patent and Trademark Office said Wednesday it has reduced the backlog of unexamined trademark applications to under 350,000, exceeding the goal the government agency set to finish the 2025 fiscal year that concluded Sept. 30.

  • October 22, 2025

    Squires Confirms USPTO Has Funds To Last The Year

    The U.S. Patent and Trademark Office has enough funds to last through the year in the event that the government shutdown continues, Director John Squires told agency personnel on Wednesday.

  • October 22, 2025

    Judge Tosses Ingenus Suit Over Leukemia Treatment Patent

    A Delaware federal judge has agreed to throw out a lawsuit accusing Hetero Labs Ltd. of infringing a patent covering a treatment for lymphoma and leukemia, pointing out that an Illinois federal court in a separate case already found the patent to be invalid.

  • October 22, 2025

    Disney Trims But Can't Defeat Thanos Tech Copyright Suit

    A fifth amended complaint from technology company Rearden LLC against Disney over alleged copyright infringement related to digital modeling technology partly survived an attempt by Disney to kill the suit Wednesday, with a judge permanently tossing a contributory infringement claim.

  • October 22, 2025

    Home Depot Passes Stewart's Threshold, But Not PTAB's

    The Patent Trial and Appeal Board has rejected Home Depot's challenge to a 12-year-old content delivery patent, after the petition made it through Deputy Director Coke Morgan Stewart's high standard for reviewing older patents. 

  • October 22, 2025

    Toyota Gets PTAB To Ax Some Car User Profile Patent Claims

    The Patent Trial and Appeal Board has invalidated some claims in a vehicle user identification patent while letting others stand in a challenge brought by Toyota Motor Corp., which has been the target of an infringement case in the Eastern District of Texas.

  • October 22, 2025

    Romanian Publisher Sues Colo. Company Over Infringement

    A Romanian publishing company asked a federal judge Wednesday to issue an injunction barring a Colorado resident from stealing its trademarked books and selling them on Amazon.

  • October 22, 2025

    Jury Convicts Man In $200M Counterfeit Smuggling Scheme

    A California federal jury has convicted a man of participating in a scheme to smuggle as much as $200 million worth of counterfeit luxury items into the U.S. through the ports of Los Angeles and Long Beach.

  • October 22, 2025

    Fed. Circ. Won't Clear Semiconductor Patent Application

    The Federal Circuit on Wednesday backed the U.S. Patent and Trademark Office's rejection of certain claims in a semiconductor patent application from a German company, sinking an appeal of findings that the claims were obvious.

  • October 22, 2025

    Anheuser-Busch Accused Of Copying Distillery's Cocktail Cans

    Philadelphia-based canned cocktail distillery Stateside Brands LLC has filed an infringement lawsuit against Anheuser-Busch, claiming the company mimicked its can logos and designs and slapped them on its own competing beverages.

  • October 22, 2025

    NC Biz Court Bulletin: COVID Coverage, A Suspect Signature

    The North Carolina Business Court has rounded the corner into fall with insurance disputes over COVID-19 coverage at a chain of outlet malls and the theft of over $900,000 in legal THC reportedly stolen from a warehouse in the Southwest.

  • October 22, 2025

    NHL Embraces Prediction Market With Kalshi, Polymarket Deals

    The National Hockey League on Wednesday announced it had entered "landmark" multiyear agreements with Polymarket and Kalshi following a recent surge in the popularity of prediction market platforms, which have also faced several recent legal challenges.

  • October 21, 2025

    Patent Landscape Shifts As Squires Takes On Key PTAB Role

    The announcement that U.S. Patent and Trademark Office Director John Squires will now make all decisions on whether to institute America Invents Act patent reviews is expected to reshape litigation, by leading fewer accused companies to file challenges, attorneys say.

  • October 21, 2025

    Sony Music Says DSW 'Sprinted' With IP Suit To Forum-Shop

    Sony Music Entertainment has urged an Ohio federal court to dismiss a suit that seeks a judgment declaring DSW's social media posts did not infringe the music label's copyrights, saying the footwear company filed suit to gain a "perceived tactical advantage" hours after Sony Music said it was preparing a complaint.

  • October 21, 2025

    Judge Trims Pharma Co. Claims Against Ex-Employees

    A Florida federal judge has narrowed pharmaceutical company Lupin Inc.'s lawsuit accusing a rival of stealing trade secrets, freeing a pair of former employees of claims that they breached their fiduciary duties by allegedly swiping the company's confidential information.

  • October 21, 2025

    Gibson Eyes Guitar TM Retrial After $1 Win Upped To $168K

    Guitar giant Gibson has asked a Texas federal judge to grant a third trial on trademark infringement claims over its iconic guitar shapes, despite getting a $1 win raised to around $168,000.

  • October 21, 2025

    10x Genomics Hits Illumina With 2 Gene Tech Patent Suits

    10x Genomics accused biotech giant Illumina Inc. of infringing nine genetic sequencing patents in two Delaware federal lawsuits Tuesday, arguing that Illumina knew of at least one of the patents because it was involved in a $31 million verdict against a different company that is well-known in the biology space.

  • October 21, 2025

    Risking Sanctions, Patent Owner Skips Google Bench Trial

    A location tracking patent owner did not show up for a bench trial on Google's equitable defenses to his infringement claims Tuesday, despite a New York federal court order saying he could be sanctioned if he did not make an appearance.

  • October 21, 2025

    Nexus Can't Pursue IP Dropped Before Trial, Del. Judge Says

    When Nexus Pharmaceuticals Inc. dropped patent claims to narrow its suit against Exela Pharma Sciences LLC, it lost the ability to assert them later on, a Delaware federal judge said Tuesday.

  • October 21, 2025

    Regeneron, Rival End Patent Fight Over Eye Med Biosimilar

    Regeneron and a South Korea-based rival it had accused of infringing several patents covering the U.S. biotech company's top eye medication Eylea have agreed to a settlement to put an end to the case filed in West Virginia federal court.

Expert Analysis

  • IP Due Diligence Tips For AI Assets In M&A Transactions

    Author Photo

    Artificial intelligence systems' integration into business operations creates new considerations for intellectual property due diligence in mergers and acquisitions and financing transactions, and implementing a practical approach to identifying AI assets can help avoid litigation and losses, say Armin Ghiam and Senna Hahn at Hunton.

  • How To Strengthen A Case By Mastering Expert Witness Prep

    Author Photo

    A well-prepared expert witness can bolster a case's credibility with persuasive qualifications, compelling voir dire responses and concise testimony that can withstand cross-examination, says Allison Rocker at Baker McKenzie.

  • A Look At Florida's New Protected Series LLC Legislation

    Author Photo

    A new law in Florida enhances the flexibility of using limited liability companies as the entities of choice for most privately held businesses, moving Florida into a small group of states with reliable uniform protected series legislation for series LLCs, says Louis Conti at Holland & Knight.

  • Opinion

    New USPTO Leadership Must Address Low-Quality Patents

    Author Photo

    With John Squires in line to become the new director of the U.S. Patent and Trademark Office, the agency has an opportunity to refocus its mission on prioritizing quality in patent examination and taking a harsher stance against low-quality patents and patent trolls, says Jill Crosby at Engine Advocacy & Foundation.

  • Opinion

    High Court Must Overrule Outdated Patent Eligibility Doctrine

    Author Photo

    A certiorari petition should directly ask the U.S. Supreme Court to correct its 1972 patent decision in Gottschalk v. Benson, the critical point where patent eligibility law veered from the statutory text toward judicial policymaking, says Robert Greenspoon at Dunlap Bennett.

  • Series

    Playing The Violin Makes Me A Better Lawyer

    Author Photo

    Playing violin in a string quartet reminds me that flexibility, ambition, strong listening skills, thoughtful leadership and intentional collaboration are all keys to a successful legal practice, says Julie Park at MoFo.

  • DOJ Enforcement Trends To Watch In 2nd Half Of 2025

    Author Photo

    Recent investigations, settlements and a declination to prosecute suggest that controlling the flow of goods into and out of the country, and redressing what the administration sees as reverse discrimination, are likely to be at the forefront of the U.S. Department of Justice's enforcement agenda the rest of this year, say attorneys at Baker Botts.

  • The State Of AI Adoption In The Patent Field

    Author Photo

    The use of generative artificial intelligence in patent-related practices has lagged behind early predictions, which may be explained by a number of core concerns that organizations must address before seriously considering adoption, say attorney Michael Drapkin and leadership coach Michael Colacchio.

  • Purdue Case Could Transform Patent Obviousness Analyses

    Author Photo

    If accepted for review by the U.S. Supreme Court, Purdue Pharma v. Accord Healthcare — concerning whether Purdue's abuse-deterrent opioid formulation patents were invalid as obvious — could significantly shift how courts weigh secondary considerations in patent obviousness analyses, say attorneys at Lathrop.

  • 'Top Gun' And 'Together' IP Suits Spotlight Similarity Issues

    Author Photo

    The outcome of recent lawsuits revolving around the films "Top Gun: Maverick" and "Together" may set meaningful precedents for how courts analyze substantial similarity in creative works, say attorneys at Greenspoon Marder.

  • Series

    Law School's Missed Lessons: Practicing Self-Care

    Author Photo

    Law schools don’t teach the mental, physical and emotional health maintenance tools necessary to deal with the profession's many demands, but practicing self-care is an important key to success that can help to improve focus, manage stress and reduce burnout, says Rachel Leonard​​​​​​​ at MG+M.

  • ABA Opinion Makes It A Bit Easier To Drop A 'Hot Potato'

    Author Photo

    The American Bar Association's recent ethics opinion clarifies when attorneys may terminate clients without good cause, though courts may still disqualify a lawyer who drops a client like a hot potato, so sending a closeout letter is always a best practice, say attorneys at Thompson Hine.

  • IRhythm IPR Denial Raises Key PTAB Discretion Questions

    Author Photo

    By giving the passage of time a dispositive role in denying institution of five inter partes review petitions filed by iRhythm Technologies, the U.S. Patent and Trademark Office has upended the strategic considerations for filing and defending against IPRs, disclosing prior art during prosecution, and engaging in licensing negotiations, say attorneys at Dentons.

  • Dupes Boom Spurs IP Risks, Opportunities For Investors

    Author Photo

    The rising popularity of dupe products has created a dynamic marketplace where both dupes-based businesses and established branded companies can thrive, but investors must consider a host of legal implications, especially when the dupes straddle a fine line between imitation and intellectual property infringement, say attorneys at Ropes & Gray.

  • Opinion

    IPR Denial In IRhythm Should Not Set A Blanket Rule

    Author Photo

    Though the Patent Trial and Appeal Board's discretionary denial in iRhythm v. Welch Allyn last month raised concerns that mere knowledge of a patent could bar inter partes review institution, a closer look at the facts and reasoning reveals why this case's holdings should not be reflexively applied to all petitioners, says David McCombs at Haynes Boone.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the sa¹ú¼Ê´«Ã½ archive.